Valuation : ResMed, Inc.

Market Cap 3.14TCr 2.7TCr 2.55TCr 2.32TCr 4.34TCr 3,00300Cr 4.38TCr 30TCr 12TCr 1,52300Cr 12TCr 12TCr 4,83900Cr P/E 2027 *
18.8x
P/E 2028 * 17.2x
Enterprise Value 3.05TCr 2.62TCr 2.47TCr 2.25TCr 4.21TCr 2,91200Cr 4.25TCr 29TCr 11TCr 1,47700Cr 11TCr 11TCr 4,69200Cr EV / Sales 2027 *
5.24x
EV / Sales 2028 * 4.8x
Free-Float
75.13%
Yield 2027 *
1.21%
Yield 2028 * 1.33%
1 day-0.19%
1 week-4.19%
Current month-8.55%
1 month-0.21%
3 months+13.44%
6 months-11.14%
Current year-8.84%
1 week 215.8
Extreme 215.8
226.66
1 month 215.8
Extreme 215.8
242.4
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
297.62
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Exercice

Chief Executive Officer

14,973 0.0104%
02/09/26 Sell

Founder

-970 0.0007%
07/08/26 Exercice

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-4.19%-18.82%+48.42% 3.14TCr
+0.98%-2.47%+26.57%+16.38% 22TCr
+0.58%-4.98%+4.12%-19.26% 14TCr
+2.62%-2.53%-19.89%+20.87% 13TCr
0.00%-8.20%-59.04%-19.99% 6.25TCr
+0.42%-1.33%-19.83%-14.98% 4.97TCr
+0.24%-3.35%+10.85%+17.15% 5TCr
+1.38%-4.57%+15.31%+25.55% 4.03TCr
+1.64%-2.88%+37.06%+52.38% 3.95TCr
+1.65%-9.20%+110.78%+27.10% 3.04TCr
Average +0.99%-3.72%+8.71%+15.36% 7.95TCr
Weighted average by Cap. +1.12%-3.36%+5.91%+9.94%

Financials

2027 *2028 *
Net sales 581.12Cr 499.77Cr 471.54Cr 429.57Cr 803.03Cr 56TCr 810.32Cr 5.62TCr 2.16TCr 28TCr 2.18TCr 2.13TCr 90TCr 619.01Cr 532.35Cr 502.28Cr 457.58Cr 855.38Cr 59TCr 863.15Cr 5.98TCr 2.3TCr 30TCr 2.32TCr 2.27TCr 95TCr
Net income 164.3Cr 141.3Cr 133.32Cr 121.45Cr 227.03Cr 16TCr 229.1Cr 1.59TCr 611.07Cr 7.97TCr 616.97Cr 603.48Cr 25TCr 178.09Cr 153.16Cr 144.51Cr 131.64Cr 246.09Cr 17TCr 248.33Cr 1.72TCr 662.36Cr 8.64TCr 668.76Cr 654.14Cr 27TCr
Net Debt -95Cr -82Cr -77Cr -71Cr -131.9Cr -9.13TCr -133.1Cr -922.44Cr -355.02Cr -4.63TCr -358.45Cr -350.61Cr -15TCr -169.17Cr -145.49Cr -137.27Cr -125.05Cr -233.77Cr -16TCr -235.89Cr -1.63TCr -629.21Cr -8.2TCr -635.28Cr -621.39Cr -26TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
11/26/11 $219.58 -0.17% 9,23,144
09/26/09 $219.95 -0.50% 12,00,149
08/26/08 $221.05 -3.20% 19,59,445
04/26/04 $228.35 -0.37% 8,43,837
03/26/03 $229.19 -0.73% 14,83,411
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
219.58USD
Average target price
246.44USD
Spread / Average Target
+12.23%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!